New pill joins fight against deadly brain cancer
NCT ID NCT04373785
Summary
This trial is testing if adding a new oral medication called NG101m to the standard treatment helps people with newly diagnosed glioblastoma live longer. About 52 adults will take NG101m capsules along with their usual chemotherapy and radiation. The main goal is to see if this combination improves the two-year survival rate and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA MULTIFORME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yvonne Kew MD, PLLC
Houston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.